Follow-The-Filings

Security · featured owners

TRDA Entrada Therapeutics Inc.

Health Care COM Equity among managers we track

TRDA (Entrada Therapeutics Inc.) 13F ownership among featured managers we track. Figures are as-filed 13F, not free float.

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

SEC filings

Recent issuer filings from EDGAR · 8 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01
10-Q
8-K 5.02,5.07,9.01
8-K 7.01,9.01
8-K 2.02,7.01,9.01
10-Q
DEFA14A
DEFA14A

Insider forms

Form 3 / 4 / 5 from EDGAR · 10 rows shown

Filed Form Detail Links
4 Period Sep 4, 2026 · 2 forms
4 Period Sep 2, 2026 · 4 forms
4 Period Sep 1, 2026 · 2 forms
4 Period Aug 27, 2026 · 2 forms
4 Period Aug 24, 2026 · 2 forms
4 Period Aug 6, 2026 · 2 forms
4 Period Jul 30, 2026 · 2 forms
4 Period Jun 10, 2026 · 6 forms
4 Period May 20, 2026
4 Period May 4, 2026 · 2 forms

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $129.01M $210.78M $25.42M
Net income -$6.68M $65.63M -$143.75M
Net margin * -5.2% 31.1% -565.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $369.77M $440.04M $306.25M
Total non-current assets * $99.42M $86.28M $71.13M
Total assets $469.19M $526.32M $377.38M
Total current liabilities $158.8M $39.48M $24.45M
Total non-current liabilities * $68.04M $58.16M $46.79M
Total equity $242.36M $428.68M $306.13M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $139.8M -$41.56M -$128.51M
Cash from investing -$138.4M -$27.8M $116.81M
Cash from financing $21.04M $102.96M $0.887M
Net change in cash $22.44M $33.61M -$10.82M

ownership over time

filing count by report period · click a bar for that quarter’s holders